Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Medios AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €16.14 |
52 Week High | €18.06 |
52 Week Low | €13.34 |
Beta | 1.09 |
11 Month Change | 12.71% |
3 Month Change | 5.49% |
1 Year Change | 0.88% |
33 Year Change | -52.46% |
5 Year Change | -6.43% |
Change since IPO | 106.95% |
Recent News & Updates
Recent updates
Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There
May 21Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly
Aug 19Is Medios AG (ETR:ILM1) Trading At A 39% Discount?
Mar 02Is Medios (ETR:ILM1) Using Too Much Debt?
Nov 27Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?
Oct 21Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly
Aug 12Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?
Jul 07Is Medios (ETR:ILM1) Using Too Much Debt?
Apr 28Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock
Mar 07What Does Medios AG's (ETR:ILM1) Share Price Indicate?
Feb 08Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet
Nov 29Is There Now An Opportunity In Medios AG (ETR:ILM1)?
Oct 02Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price
Jun 18What Is Medios AG's (ETR:ILM1) Share Price Doing?
May 25Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts
Jan 21What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition
Jan 19Is It Time To Consider Buying Medios AG (ETR:ILM1)?
Dec 24Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week
Dec 09The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It
Dec 08Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 22What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?
Jun 22Shareholder Returns
ILM1 | DE Healthcare | DE Market | |
---|---|---|---|
7D | -3.1% | -0.5% | -0.1% |
1Y | 0.9% | -2.1% | 2.3% |
Return vs Industry: ILM1 exceeded the German Healthcare industry which returned -2.1% over the past year.
Return vs Market: ILM1 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
ILM1 volatility | |
---|---|
ILM1 Average Weekly Movement | 5.1% |
Healthcare Industry Average Movement | 5.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: ILM1 has not had significant price volatility in the past 3 months.
Volatility Over Time: ILM1's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 500 | Matthias Gaertner | www.medios.ag |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.
Medios AG Fundamentals Summary
ILM1 fundamental statistics | |
---|---|
Market cap | €411.73m |
Earnings (TTM) | €17.97m |
Revenue (TTM) | €1.81b |
22.9x
P/E Ratio0.2x
P/S RatioIs ILM1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ILM1 income statement (TTM) | |
---|---|
Revenue | €1.81b |
Cost of Revenue | €1.70b |
Gross Profit | €107.44m |
Other Expenses | €89.47m |
Earnings | €17.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 13, 2024
Earnings per share (EPS) | 0.70 |
Gross Margin | 5.94% |
Net Profit Margin | 0.99% |
Debt/Equity Ratio | 0% |
How did ILM1 perform over the long term?
See historical performance and comparison